CRISPR/Cas9, a new approach to successful knockdown of ABCB1/P-glycoprotein and reversal of chemosensitivity in human epithelial ovarian cancer cell line.
about
CRISPR/Cas9, a new approach to successful knockdown of ABCB1/P-glycoprotein and reversal of chemosensitivity in human epithelial ovarian cancer cell line.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
CRISPR/Cas9, a new approach to ...... lial ovarian cancer cell line.
@en
CRISPR/Cas9, a new approach to ...... lial ovarian cancer cell line.
@nl
type
label
CRISPR/Cas9, a new approach to ...... lial ovarian cancer cell line.
@en
CRISPR/Cas9, a new approach to ...... lial ovarian cancer cell line.
@nl
prefLabel
CRISPR/Cas9, a new approach to ...... lial ovarian cancer cell line.
@en
CRISPR/Cas9, a new approach to ...... lial ovarian cancer cell line.
@nl
P2093
P2860
P921
P1476
CRISPR/Cas9, a new approach to ...... lial ovarian cancer cell line.
@en
P2093
Leyla Norouzi-Barough
Mohammadreza Sarookhani
Rasoul Salehi
Sahar Moghbelinejad
P2860
P304
P356
10.22038/IJBMS.2017.25145.6230
P577
2018-02-01T00:00:00Z